Intellia Therapeutics Inc buy Morgan Stanley
Start price
13.11.23
/
50%
€21.86
Target price
13.11.24
€79.49
Performance (%)
-29.07%
End price
14.11.24
€15.51
Summary
This prediction ended on 14.11.24 with a price of €15.51. The price of Intellia Therapeutics Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.07%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 7.993% | 7.993% | 89.044% |
| iShares Core DAX® | -0,68 % | 4,05 % | 2,21 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % | 38,04 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % | 59,00 % |
| iShares S&P 500 | 0,62 % | 6,20 % | 26,15 % |
Comments by Morgan_Stanley for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Morgan Stanley from $90.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten